Growth Factors & Cytokines

Recombinant Human Flt3-Ligand

0 ReviewsSubmit a Review

Product Details

Catalogue Number: 300-19
Description:
Recombinant Human Flt3-Ligand

Flt3-Ligand is a growth factor that regulates proliferation of early hematopoietic cells. Flt3-Ligand binds to cells expressing the tyrosine kinase receptor Flt3. Flt3-Ligand, by itself does not stimulate proliferation of early hematopoietic cells, but synergizes with other CSFs and interleukins to induce growth and differentiation. Unlike SCF, Flt3-Ligand exerts no activity on mast cells. Multiple isoforms of Flt3-Ligand have been identified. The predominant biologically active form is anchored to the cell surface as the extracellular domain of a transmembrane protein (209 a.a.). The membrane-bound isoform can be proteolytically cleaved to generate a biologically active soluble isoform. Recombinant Human Flt3-Ligand is a soluble 17.6 kDa protein consisting of 155 amino acid residues.

Source: E.coli

Synonyms: Fms-related tyrosine kinase 3 ligand, Flt3L

AA Sequence: TQDCSFQHSP ISSDFAVKIR ELSDYLLQDY PVTVASNLQD EELCGGLWRL VLAQRWMERL KTVAGSKMQG LLERVNTEIH FVTKCAFQPP PSCLRFVQTN ISRLLQETSE QLVALKPWIT RQNFSRCLEL QCQPDSSTLP PPWSPRPLEA TAPTA

Purity: ≥ 98% by SDS-PAGE gel and HPLC analyses.

Biological Activity: The ED50 was determined by the dose-dependent stimulation of the proliferation of human AML5 cells is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 106 units/mg.

This product has been tested against the WHO standard. International Unit information can be found here.

Calculated Molecular Weight: 17.6 kDa

Accession Number: P49771

Gene ID: 2322

crossreactivity:
Country Of Origin: USA

Not for human use.

Research Interest

product.subtitle.recentcitations

First Author
Tvorogov, D
Title
Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody.
Citation
EMBO reports; 23(4) pge52904
PubMed Id
First Author
Rice, S
Title
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program.
Citation
Nature Communications; 12(1) pg6905
PubMed Id
First Author
Kim, H
Title
Directly reprogrammed natural killer cells for cancer immunotherapy
Citation
Nature Biomedical Engineering; 5(11) pg1360-1376
PubMed Id